Skip to main content
. Author manuscript; available in PMC: 2011 Oct 30.
Published in final edited form as: Am J Hypertens. 2011 Jun 30;24(10):1149–1155. doi: 10.1038/ajh.2011.114

Figure 4.

Figure 4

Effect of Ang II on insulin-induced glucose uptake. VSMCs were treated with 100 nmol/l Ang II or vehicle for 18 h in the presence or absence of an ARB, exposed to 10 nmol/l insulin for 30 min, and 2-deoxy-D-[3H]-glucose uptake measured. Data represent mean ± s.e. (n = 10) of percent change in uptake. *P < 0.05 vs. control. Ang II, angiotensin II; ARB, Ang II type 1 receptor blockers; VSMCs, vascular smooth muscle cells.